Subscribe
Call Us: 02380 97 07 33

Archive for February 2011

Adieu: Southampton Branch of the Royal Pharmaceutical Society

Adieu: Southampton Branch of the Royal Pharmaceutical Society

– Annals of a sentimental foot soldier by Kazeem Olalekan MRPharmS The last meeting of the Southampton Branch of the Royal Pharmaceutical Society was held on the 22nd of April 2010 at the Drug Safety Research Unit (DSRU) located at Blundell Lane in Bursledon, Southampton. The location […]

Read more

The PDA Annual Conference 2011

The PDA Annual Conference 2011

by Kazeem Olalekan MRPharmS The Pharmacy Pharmacists’ defence association (PDA) has fixed this year’s conference for the 26th & 27th February 2011. Bookapharmacist.com is recommending all pharmacists who can attend this event to do so – whether they are members of the PDA or not. The conference […]

Read more

A listening group–the ASDA example

Bookapharmacist.com welcomes the bold move by the Superintendent of Asda Pharmacy, John Evans to lead the formation of a Listening group for locum pharmacists. He posted a comment on the Locum Voice website on the 31st of December (link), in which he describes his company’s keenness to […]

Read more

Pharmacist and Sexual Health

Pharmacist and Sexual Health

Just uncovered this video on YouTube highlighting how pharmacists can play a role in public health in the area of sexual health. The pharmacist can do a lot more of course. So just remember to ask your pharmacist about what helps are available locally. Check the NHS […]

Read more

Change, Stress and Support

Change, Stress and Support

by Kazeem Olalekan Change management has been described as structured approach to shifting/transitioning individuals, teams, and organizations from a current state to a desired future state (Wikipedia). UK Pharmacy PLC has undergone and is undergoing significant changes in the way it is configured. With change comes uncertainties […]

Read more

Drug Safety Alert – Dronedarone

Drug Safety Alert – Dronedarone

Dronedarone (Multaq▼) is an antiarrhythmic agent indicated in adult, clinically stable patients with history of, or current, non-permanent atrial fibrillation (AF) to prevent recurrence of AF or to lower ventricular rate. Dronedarone is available as a 400 mg film-coated tablet and the recommended dose is 400 mg […]

Read more

Class 3 Drug Alert: Novgos 3.6 mg Implant

Class 3 Drug Alert: Novgos 3.6 mg Implant

Action within 5 days Genus Pharmaceuticals Ltd is temporarily ceasing manufacture of the above product and recalling all remaining stock from pharmacy and wholesaler level. This is due to a small number of problems during implantation and the product is being withdrawn until the implantation system can […]

Read more

Disclaimer

The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.